- Home
- HST vs QGEN Comparison
HST vs QGEN Comparison
Compare HST & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HST | QGEN |
|---|---|---|
| Founded | 1927 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | HST | QGEN |
|---|---|---|
| Price | $18.43 | $45.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $18.65 | ★ $50.07 |
| AVG Volume (30 Days) | ★ 7.1M | 1.1M |
| Earning Date | 11-05-2025 | 02-04-2026 |
| Dividend Yield | ★ 5.15% | 3.33% |
| EPS Growth | 3.27 | ★ 331.20 |
| EPS | 1.06 | ★ 1.84 |
| Revenue | ★ $5,950,000,000.00 | $2,070,781,000.00 |
| Revenue This Year | $6.54 | $7.07 |
| Revenue Next Year | $1.75 | $6.14 |
| P/E Ratio | ★ $17.42 | $24.67 |
| Revenue Growth | ★ 6.44 | 5.32 |
| 52 Week Low | $12.22 | $37.63 |
| 52 Week High | $18.72 | $51.88 |
Technical Indicators
Market Signals| Indicator | HST | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 58.15 | 45.64 |
| Support Level | $18.23 | $45.13 |
| Resistance Level | $18.69 | $46.17 |
| Average True Range (ATR) | 0.39 | 0.66 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 82.13 | 39.50 |
Price Performance
Historical ComparisonAbout HST Host Hotels & Resorts Inc.
Host Hotels & Resorts owns 80 predominantly urban and resort upper-upscale and luxury hotel properties representing nearly 43,000 rooms, mainly in the United States. Host recently sold off the company's interests in a joint venture owning a portfolio of hotels throughout Europe and also sold other joint ventures that owned properties in Asia and the United States. The majority of Host's portfolio operates under the Marriott and Starwood brands.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).